V-Square Quantitative Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$632K Buy
6,110
+294
+5% +$26.2K 0.06% 281
2026
Q1
$418K Sell
5,816
-587
-9% -$45.2K 0.04% 345
2025
Q4
$508K Sell
6,403
-4,168
-39% -$329K 0.05% 314
2025
Q3
$797K Buy
10,571
+96
+0.9% +$6.58K 0.13% 124
2025
Q2
$723K Sell
10,475
-6,605
-39% -$433K 0.1% 217
2025
Q1
$1.16M Sell
17,080
-1,267
-7% -$75.8K 0.17% 126
2024
Q4
$824K Buy
18,347
+2,586
+16% +$145K 0.12% 183
2024
Q3
$991K Buy
15,761
+2,811
+22% +$164K 0.15% 138
2024
Q2
$765K Buy
12,950
+505
+4% +$31.6K 0.12% 156
2024
Q1
$993K Buy
12,445
+4,989
+67% +$381K 0.14% 120
2023
Q4
$589K Buy
7,456
+4,421
+146% +$315K 0.1% 175
2023
Q3
$212K Buy
3,035
+2,929
+2,763% +$208K 0.09% 291
2023
Q2
$7.33K Buy
+106
New +$7.54K 0.01% 463

Other funds holding CVS

V-Square Quantitative Management's CVS Position: Q2 2026 in Review

V-Square Quantitative Management increased its CVS Health (CVS) stake by 5.1% in Q2 2026, buying an estimated $26.2K and bringing the position to 6,110 shares worth $632K. The position accounts for 0.06% of the portfolio, ranked #281.

V-Square Quantitative Management first reported a position in CVS in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.16M in Q1 2025. 865 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • V-Square Quantitative Management held 6,110 shares of CVS Health worth $632K as of Q2 2026.
  • V-Square Quantitative Management bought 294 CVS Health shares in Q2 2026, an estimated $26.2K.
  • CVS Health made up 0.06% of V-Square Quantitative Management's portfolio in Q2 2026, its #281 holding.
  • V-Square Quantitative Management first reported a position in CVS Health in Q2 2023 and has held it in 13 quarters since.
  • V-Square Quantitative Management's CVS Health position peaked at $1.16M in Q1 2025.
  • 865 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.